AML	Acute myeloid leukaemia
CA-1	Combretastatin A-1
CA-4	Combretastatin A-4
CA-4P	Combretastatin A-4 phosphate
CBS	Colchicine-binding site
CBSI	Colchicine-binding site inhibitor
DAMA-colchicine	N-deacetyl-N-(2-mercaptoacetyl) colchicine
DAPI	4′,6-diamidino-2-phenylindole
EGFR	Epidermal growth factor receptor
FITC	Fluorescein isothiocyanate
GDP	Guanosine diphosphate
GEP-NETs	Gastro-entero-pancreatic neuroendocrine tumours
GTP	Guanosine triphosphate
HCC	Hepatocellular carcinoma
HDAC	Histone deacetylase enzyme
KRAS	Kirsten rat sarcoma viral analogue homologue
MDR	Multi-drug resistance
MDS	Myelodysplastic syndrome
MTA	Microtubule-targeting agent
NLRP3	nucleotide-binding domain (NOD)-like receptor protein
NSCLC	Non-small-cell lung carcinoma
P-gp	P-glycoprotein
PPTP	Paediatric preclinical testing program
SAR	Structure–activity relationship
UGT	UDP-glucuronyl transferase
VDA	Vascular-disrupting agent
VEGFR	Vascular endothelial growth factor receptor